CALGARY, AB, CANADA, January 13, 2021

/EINPresswire.com/ — Kent Imaging, an innovator in the tissue imaging market, announced today its partnership with TVM Life Science Innovation II SCSp to accelerate the global commercialization of its industry leading SnapshotNIR® product.

SnapshotNIR utilizes near infrared light to determine tissue oxygen saturation (StO2), which is a key indicator of tissue health. Snapshot NIR assesses the microcirculation and conveys a comprehensive picture of tissue health and the healing capacity of wounds or surgical tissue. This FDA cleared, non-invasive approach to tissue assessment brings value to healthcare delivery in various clinical settings including wound care, plastic and reconstructive surgery, and vascular surgery.

“The confidence expressed by TVM in Kent’s products and technology reinforces our leadership in bringing innovation to this critical market. With this investment, Kent will expand on its product line, its partnerships and accelerate the introduction of this novel technology globally.” – Pierre Lemire, CEO Kent Imaging

“Kent Imaging commercializes innovative oxygenation imaging products targeting limb preservation and reconstructive surgical markets. This is an area with clear unmet need as non-healing wounds are a huge burden with respect to patient outcome and ever rising healthcare costs. TVM’s investment will further establish Kent Imaging on the global stage. We see Kent’s technology as the next major imaging modality and we are excited to be a part of the initiative to bring this technology to the global market. Kent Imaging will benefit from TVM Capital Life Science’s European and North American network to facilitate its market access abroad.” – Dr. Luc Marengere, Managing Partner, TVM Capital Life Science

In addition to the investment, Kent Imaging will also benefit with the addition of Dr. Luc Marengere and Dr. Alexandra MacLean, a Principal with TVM Capital Life Science, to its Board of Directors.

About Kent Imaging Inc.

Kent Imaging, located in Calgary, Alberta, Canada, is a leading innovator in oxygenation imaging, who develops, manufactures and markets medical technology that supports real-time decision making in wound care, vascular and surgical sub-specialties. Kent holds multiple patents in oxygen imaging technology and continues to provide innovative and advanced diagnostic imaging solutions to aid healthcare systems nationally